SEC Form 4 · accession 0001209191-15-002621
KERYX BIOPHARMACEUTICALS INC · KERX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James F Oliviero III
Officer — Chief Financial Officer
Period of report
Jan 4, 2015
Accepted (ET)
Jan 6, 2015 · 8:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001114220
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 4, 2015 | A | 23,875 | $0.00 | A | 177,220 | D | |
| Common StockF3,F2 | Jan 5, 2015 | S | 5,604 | $13.79 | D | 171,616 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F4 | $14.34 | Jan 4, 2015 | A | 47,750 | A | Jan 4, 2016 | Jan 4, 2025 | Common Stock | 47,750 | 47,750 | D |
Explanation of responses
- F1The 23,875 shares are restricted common stock, with one-third of the 23,875 shares vesting on January 4, 2016, and one-twelfth vesting on each of April 4, 2016, July 4, 2016, October 4, 2016, January 4, 2017, April 4, 2017, July 4, 2017, October 4, 2017, and January 4, 2018.
- F2Includes 50,205 shares of restricted stock.
- F3Sale of a total of 5,604 shares of common stock was made in order to satisfy Mr. Oliviero's income tax withholding obligation upon the vesting of 12,703 shares of restricted stock on January 2, 2015. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- F4The options vest according to the following schedule: one-third of the 47,750 options will vest on January 4, 2016, and one-twelfth will vest on each of April 4, 2016, July 4, 2016, October 4, 2016, January 4, 2017, April 4, 2017, July 4, 2017, October 4, 2017, and January 4, 2018.